[New concept on diagnosis and therapy for rheumatoid and collagen diseases (discussion)].
Shunichi
S
Kumagai
Kazuhiko
K
Yamamoto
Akira
A
Sagawa
Takashi
T
Nakazawa
Peter
P
Shane
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001323:Autoantibodies; D003095:Collagen Diseases / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D003952:Diagnostic Imaging; D004359:Drug Therapy, Combination; D005081:Exercise Therapy; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007348:Insurance, Health / Q000191:economics; D007564:Japan; D007596:Joints / Q000473:pathology; D008727:Methotrexate / Q000008:administration & dosage; D012216:Rheumatic Diseases / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D012698:Serologic Tests; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D001323:Autoantibodies; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D008727:Methotrexate